Pharma Journalist -

Amneal Pharmaceuticals, Inc. and Kashiv BioSciences LLC announced they have entered into a definitive agreement under which Amneal Pharmaceuticals LLC, a wholly-owned subsidiary of the…
Read More...

Merck, known as MSD outside the United States and Canada, announced the U.S. Food and Drug Administration (FDA) accepted for priority review a Biologics License Application (BLA) for…
Read More...

Boehringer Ingelheim and Enara Bio announced that they have entered into a strategic collaboration and licensing agreement to research and develop novel targeted cancer immunotherapies,…
Read More...

Bayer announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) and granted Priority Review for finerenone, an investigational drug for…
Read More...

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that Swissmedic, the Swiss Agency for Therapeutic Products, has authorized the…
Read More...

AvantGen, Inc., a San Diego-based biotechnology company with an array of technology platforms for antibody discovery and optimization, and novel NK and T cell engager generation,…
Read More...

BeiGene, Ltd. a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, announced a collaboration and license agreement with…
Read More...

Rocket Pharmaceuticals, Inc. a clinical-stage company advancing an integrated and sustainable pipeline of genetic therapies for rare childhood disorders, today announces the Company’s…
Read More...

Sanofi and Kymab, a clinical-stage biopharmaceutical company developing fully human monoclonal antibodies with a focus on immune-mediated diseases and immuno-oncology therapeutics, have…
Read More...

SMi Reports: Conference Chairman Darren Green from GSK personally invites you the 2nd Annual AI in Drug Discovery Conference taking place on 15 and 16h March 2021 as a virtual…
Read More...